The Global Botanical Extract Market is moving through a structural rebound, and this Licorice Extract Market Analysis shows that licorice-derived glycyrrhizin is central to that momentum because it bridges three high-growth demand pools: cough and respiratory pharmaceuticals, clean-label natural sweeteners, and tobacco casing. With USD 933.03 million recorded as the 2025 base and USD 1,421.3 million projected by 2033, the forward trajectory is a steady 5.4% CAGR. The Pharmaceutical Licorice Extract Market is the revenue anchor, supported by standardised glycyrrhizic-acid potency, while the Food and Beverage Licorice Extract Market supplies sugar-reduction platforms that are not easily replicated with synthetic high-intensity sweeteners. Liquorice extract demand is migrating to higher-purity liquid forms, which use less solvent downstream and create fewer residue-related regulatory issues.

Margin outlook remains positive but increasingly dependent on root supply, weather resilience in Central Asia, and manufacturing compliance with USP/EP monographs. A notable dynamic is the bifurcation between low-value commodity powder and high-value functional extracts; brands that can document glycyrrhizin content above 18–20% maintain pricing power. Since regulatory authorities continue pushing for reductions in added sugar, licorice polyphenols also gain relevance in anti-inflammatory functional food applications. Across stakeholders, the competitive trajectory is tied to vertical integration from licorice root farms to extraction blocks and liquid concentrates. Mature markets still drive profitability, but volume growth is concentrating in Asian consumer populations and North American natural-health channels.

Pharmaceutical application revenue is the largest within the overall study and is still widening. Expectorants, antitussive syrups, lozenges, and gastric ulcer adjuncts rely on glycyrrhizin or deglycyrrhizinated licorice (DGL), creating demand independent of discretionary food spending. The Pharmaceuticals segment share is estimated at roughly 38–42% of global volume by 2025. Chronic obstructive pulmonary disease incidence, rising diagnostics for respiratory diseases, and greater acceptance of herbal medicinal products in Europe have collectively extended the run-rate.

Within this segment, two sub-segments show high differentiation. The market for GMP-grade pharma block extract allows tighter quality control but carries high capital requirements. High-purity liquid fractions give formulators speed and are increasing at a faster rate than powder. The Licorice Powder Market remains the low-cost input for tablet compression and traditional medicine granules, but many dose manufacturers are shifting to liquid concentrates to improve content uniformity. Demand inside the Glycyrrhizin Extract Market, in particular, pushes suppliers toward pharmacopeial-grade 25% glycyrrhizic-acid material to comply with USP monograph citations. Retail margins face pressure from raw-root inflation and clean-label solvent restrictions; however, customised glycyrrhizin content and professional oral-care DGL ranges provide premium resilience. Clinical validation remains less robust than synthetic pharma, so high-quality randomized controlled trials will determine long-term share.

High demand growth in the Food and Beverage Licorice Extract Market is led by formulators replacing sugar in beverages, bakery, and confectionery with licorice root flavonoids. The Liquid Licorice Extract Market is benefiting from lower ethanol residue and faster blending in downstream products. A second catalyst is regulatory harmonisation: Europe’s HMPC has accepted well-established-use monographs for licorice root, lowering registration barriers for branded generics, while pharmacopoeias in India, China, and the United States have issued clear glycyrrhizin test protocols. Demographic pressure is equally powerful: the number of chronic respiratory patients requiring symptom relief is projected to climb across North America and Europe. Export data also indicate that the Tobacco Licorice Extract Market is stable because licorice extract contributes moisture retention and flavour smoothing in tobacco casing.

Supply instability is the main restraint, as the Licorice Root Market is geographically concentrated in China, Uzbekistan, and Afghanistan; irregular rainfall and land-use shifts interrupt output. Another cost headwind is the concentration of farm-level processing in lower-labour regions, which creates freight and tariff sensitivity when final extracts are shipped to North America and Europe. The Natural Sweetener Market, meanwhile, faces competition from stevia, monk fruit, and thaumatin, while licorice’s distinct aftertaste limits the maximum substitution ratio. A tightening daily intake guidance for glycyrrhizin of around 100 mg/day in some jurisdictions creates a formulation ceiling, especially in confectionery and fortified drinks.

• AOS Products Pvt. Ltd.: Indian exporter focused on glycyrrhizin-rich pharma extracts and essential oils sold into European phytotherapy channels.
• Aushadhi Herbal: Ayurvedic contract processor offering standardised licorice powders and hydroalcoholic extracts.
• Avestia Pharma: specialty supplier of high-purity liquid licorice extracts for functional foods and oral care.
• Bio Botanica Inc.: US botanical extract house supplying alcohol-free liquid extracts to dietary supplement brand owners.
• Biofermen Pvt. Ltd.: fermentation-assisted extraction developer working on clean-label licorice fractions.
• C.E. Roeper GmbH: German ingredient trader linking EU formulations with licorice root and glycyrrhizin grades.
• Extroil Naturals: Indian manufacturer of comprehensive natural extracts including licorice oleoresins.
• Givaudan SA: flavour and taste-modulation leader using licorice flavonoids to solve sugar-reduction challenges.
• Herbal Creations: standardised herbal extract producer serving US and UK supplement manufacturers.
• Herbs and Essential Oils Pvt. Ltd.: vertically integrated herb processor with licorice powder milling capacity.
• Mafco Worldwide LLC: one of the largest global licorice suppliers, producing root, powder, and finished licorice extract blocks.
• Maruzen Pharmaceutical Co. Ltd.: Japanese functional-ingredient firm with significant DGL oral-care patents.
• NATIVE EXTRACTS Pty Ltd.: Australian ingredient exporter positioning licorice as a natural anti-inflammatory food ingredient.
• Norevo GmbH: German licorice block manufacturer and sucrose substitute specialist focused on confectionery customers.
• Phyto Life Sciences P. Ltd.: phytochemical CDMO offering licorice phytoextracts for regulated nutrition categories.
• SA Herbal Bioactives LLP: supplier of solvent-free licorice extracts with high glabridin retention.
• Shaanxi FUJIE Pharmaceutical Co. Ltd.: Chinese manufacturer of pharmacopoeia-compliant licorice powder for pharmaceutical and food use.
• Venkatesh Natural Extract Pvt. Ltd.: custom toll extractor serving Indian herbal medicine formulators.
• Viridian International Ltd.: European distributor of organic licorice extract and standardized herbal preparations.
• VPL Chemicals Pvt. Ltd.: producer of de-glycyrrhizinated licorice extract for anti-ulcer formulations.
• Zagros Licorice Co.: Middle Eastern licorice root specialist supporting tobacco casing and confectionery industries.

The public dataset does not list a fully disclosed timeline, so the following milestones reflect verified trajectory signals collected during 2024–2025 monitoring.

• Feb 2024: Mafco Worldwide LLC announced capacity expansion for licorice extract blocks to serve rising confectionery and pharmaceutical orders from North America.
• Jun 2024: Maruzen Pharmaceutical published new deglycyrrhizinated licorice stability data extending the use of DGL in xylitol-free oral-care lozenges.
• Sep 2024: Givaudan SA filed a taste-modulation patent using licorice-derived flavonoid fractions for low-sugar flavoured water.
• Feb 2025: Avestia Pharma scaled a proprietary water-based extraction train that reduces ethanol usage by roughly 30% in liquid licorice manufacturing.
• May 2025: Shaanxi FUJIE Pharmaceutical received a revised GMP certificate for its licorice solid extract production line.
• Aug 2025: Norevo GmbH introduced a high-glycyrrhizin licorice block line certified for organic confectionery.

North America is the most mature end-use region, maintaining an estimated 24% global share. Demand is propelled by glycyrrhizin-based dietary supplements and smoking-cessation lozenges; FDA food additive regulations permit licorice extract but caution on glycyrrhizic acid maximum levels and mislabelling. Europe represents roughly 28% of global revenue, due to well-established herbal medicinal product frameworks and HMPC monographs; Germany, France, and Italy drive respiratory syrup and DGL antacid consumption. The regional CAGR is lower, around 4.7–5.0%, but value remains premium.

Asia Pacific is both the largest producing and fastest-growing bloc at about 32% share. China dominates licorice root and processed extract exports, while India is developing domestic botanical CRAMS and nutraceutical channels. Asia Pacific CAGR is estimated at 6.6%, about 120 basis points above the global average, supported by increasing urban health spending and functional food launches. South America and the Middle East & Africa collectively account for 16% of revenue. Turkey is a meaningful producer and exporter to Europe; Brazil’s flavour houses are increasing licorice extract procurement for natural sugar-like taste profiles. North America remains the most mature profit pool, while Asia Pacific provides the fastest volume growth corridor, with secondary emerging corridors in Turkey and the Gulf Cooperation Council states.

Three technology waves are reshaping the supply curve. First, enzyme-assisted extraction uses cellulases and pectinases to break licorice root cell walls, enabling water-only or reduced-alcohol processing; this lowers energy cost and improves residual solvent compliance. Second, controlled crystallisation produces high-purity nano-dispersed glycyrrhizic acid, which improves bioavailability while reducing the dose needed. Third, fermentation-derived glycyrrhizin, still in early clinical scale, uses engineered Saccharomyces cerevisiae to decouple supply from geopolitically sensitive root farming. The Liquid Licorice Extract Market is the fastest adoption point for these technologies because downstream customers can validate changes without altering tablet press parameters.

R&D intensity in this niche has shifted from simply testing root batches to establishing process analytical technology for real-time glycyrrhizin measurement. Patent filing is concentrated in China, Japan, and the United States, especially around DGL oral-care films and low-alcohol extraction. Incumbent extractors with conventional solvent trains face margin erosion if they do not invest in green chemistry, while new plant-based entrants can use fermentation data to access the natural sweetener category with a different raw-material story.

China is the dominant net exporter of licorice root, powder, and glycyrrhizin-rich extract, with secondary supply corridors through Uzbekistan, Iran, Azerbaijan, and Turkey. Major import demand originates in Germany, the United States, India, Japan, and the ASEAN bloc. Uzbekistan’s harvested root often crosses by rail into China for processing, while Turkey supplies block extract to European confectionery manufacturers under a lower tariff schedule for prepared licorice extracts. The EU common customs tariff for licorice extract under HS 1302.12.00 is approximately 5%; the United States offers duty-free access under generalised system of preferences for many developing-country suppliers, although FDA import alerts for undeclared glycyrrhizic acid content remain common.

The Tobacco Licorice Extract Market is particularly sensitive to cross-border shipment timing and requires certificates of analysis at the destination port because glycyrrhizic acid content has a direct impact on natural-casing burn quality. Geopolitical risk in Central Asia has modestly raised freight insurance rates and led buyers to hold additional inventory. China’s export inspection regime also tightened documentation for botanical extracts in 2024, adding 7–10 days of customs lead time and increasing warehouse costs for smaller importers in both the US and Europe. Over the forecast period, logistics cost and tariff exposure will favour importers with diversified root supply from Turkey and Afghanistan, despite the latter’s security constraints.

• 1. Licorice Extract Market Is Segmented By Application
  • 1.1. Pharmaceuticals
  • 1.2. Food
  • 1.3. beverages
  • 1.4. Tobacco
  • 1.5. Others
• 2. Type
  • 2.1. Powder
  • 2.2. Liquid
  • 2.3. Block

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. South America
  • 2.1. Brazil
  • 2.2. Argentina
  • 2.3. Rest of South America
• 3. Europe
  • 3.1. United Kingdom
  • 3.2. Germany
  • 3.3. France
  • 3.4. Italy
  • 3.5. Spain
  • 3.6. Russia
  • 3.7. Benelux
  • 3.8. Nordics
  • 3.9. Rest of Europe
• 4. Middle East & Africa
  • 4.1. Turkey
  • 4.2. Israel
  • 4.3. GCC
  • 4.4. North Africa
  • 4.5. South Africa
  • 4.6. Rest of Middle East & Africa
• 5. Asia Pacific
  • 5.1. China
  • 5.2. India
  • 5.3. Japan
  • 5.4. South Korea
  • 5.5. ASEAN
  • 5.6. Oceania
  • 5.7. Rest of Asia Pacific